Halazepam

CHEMBL970 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
352.7 g/mol
LogP
4.0
Phase
4

This benzodiazepine medication acts on the central nervous system to produce anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. It was used to treat anxiety disorders but has been withdrawn from the market in some countries. Like all benzodiazepines, it carries a risk of dependence and withdrawal symptoms with prolonged use.

Peso molecular

352,7000 g/mol

LogP

4,00

TPSA

32,70 Ų

Regla de cinco de Lipinski

Cumple

Mecanismo de acción

Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F

InChI

InChI=1S/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2

Molecular Formula

C17H12ClF3N2O

HBD / HBA

- / 5

Enlaces Rotables

2

Átomos Pesados

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This benzodiazepine medication acts on the central nervous system to produce anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. It was used to treat anxiety disorders but has been withdrawn from the market in some countries. Like all benzodiazepines, it carries a risk of dependence and withdrawal symptoms with prolonged use.

Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.

Yes, Halazepam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL970. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 31640. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.